Programm

10:00 am

Georg Schütte
State Secretary | Federal Ministry of Education and Research (BMBF) (tbc)

Günther Wess
Vice-President Research Field Health | Helmholtz Association

Axel Radlach Pries   
Charité – Universitätsmedizin Berlin | Dean BIH | Chairman of the Executive Board

Karl Einhäupl   
Chairman of the Executive Board | Charité – Universitätsmedizin Berlin (tbc)

Megan Frisk   
Associate Editor | Science Translational Medicine

Georg Duda   
Deputy Director | Berlin-Brandenburg Center for Regenerative Therapies (BCRT)

10:30 am

Translational research within universities and beyond
Hans-Gustaf Ljunggren | Karolinska Institutet

Challenges of moving academic research into the clinic and beyond
Jeffrey Bluestone | UCSF School of Medicine

Regulatory aspects in the translation of gene and cell therapies
Martina Schuessler-Lenz | Paul-Ehrlich-Institut

Consensus data standards – Unified data for biomarkers with focus on regulatory science
Klaus Romero | Critical Path Institute

1:45 pm

Accelerating the pace at which lifesaving treatments reach patients
Heyo K. Kroemer | Universitätsmedizin Göttingen

Catalyzing translational innovation

Governmental influences on drug development: How to strike a better balance?
Günther Wess | Helmholtz Association

How can regulators and scientists improve translation?
Barbara Casadei | University of Oxford

4:00 pm

1. Mentoring the next generation of clinical and translational researchers
Chair: Marc McKee | McGill University
Co-Chair: Georg Duda| Berlin-Brandenburg Center for Regenerative Therapies

2. Animal models in biomedical research: Improving utility and translation – cancer research and therapeutics as an example
Chair: Robert Kerbel | University of Toronto
Co-Chair: Ulrich Dirnagl | Charité Universitätsmedizin - Berlin

3. Citizen Science - Opportunities and challenges for translational research
Chair: Ernst Hafen | ETH Zürich
Co-Chair: Holger Gerhardt | Max Delbrück Center for Molecular Medicine

4. Business and entrepreneurial aspects of translational medicine
Chair: Glenn Prestwich | University of Utah
Co-Chair: Andrew Williamson | Heraeus Medical GmbH

5. Clinical Research Units – Solution for integrating translational research into the clinical practice. Industry and clinical perspectives
Chair: Ronenn Roubenoff | Novartis Institutes for Biomedical Research
Chair: Barbara Casadei | University of Oxford
Co-Chair: Mohamed Abou El-Enein | Berlin-Brandenburg Center for Regenerative Therapies

6:30 pm

Speeding up drug discovery and development: The Human Brain Project approach
Université de Lausanne

9:00 pm

Accelerating translational research in cancer
Robert C. Bast, Jr. | MD Anderson Cancer Center 

Successful strategies across the early-stage translational research
 Roche

New approaches to value-driven drug development
Stefanie Dimmeler | University of Frankfurt

From Systems Biology to Systems Medicine: The art is in the integration
Rudi Balling | University of Luxembourg

Strengthening external research partnerships, particularly with industry
Abhay Pandit | National University of Ireland

 11:30 pm

1. Mentoring the next generation of clinical and translational researchers

2. Animal models in biomedical research: Improving utility and translation – cancer research and therapeutics as an example

3. Citizen Science - Opportunities and challenges for translational research

4. Business and entrepreneurial aspects of translational medicine

5. Clinical Research Units – Solution for integrating translational research into the clinical practice. Industry and clinical perspectives

 2:15 pm

Regenerative Medicine Build-Out for an Aging Global Population
Andre Terzic | Mayo Clinic

Developing critical research and training infrastructure with limited resources
Jackson Orem | Uganda Cancer Institute

The art of funding biomedical innovation: A global perspective
Edward Holmes | Paul-Ehrlich-Institut

Accelerating the translation of global health innovations toward real solutions for the benefit of patients
Steve Kern | Bill & Melinda Gates Foundation

Evaluating and developing translational products
David Mooney | Harvard University

Efficient translational strategies: Innovations that connect with the heart
Volkmar Falk | Deutsches Herzzentrum Berlin

4:30 pm

Megan Frisk | Science Translational Medicine

Georg Duda | Berlin-Brandenburg Center for Regenerative Therapies